Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer
Endoglin (CD105) 导致铂类耐药,是上皮性卵巢癌肿瘤特异性治疗的靶点
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-12-1045
Angela J Ziebarth, Somaira Nowsheen, Adam D Steg, Monjri M Shah, Ashwini A Katre, Zachary C Dobbin, Hee-Dong Han, Gabriel Lopez-Berestein, Anil K Sood, Michael Conner, Eddy S Yang, Charles N Landen